- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06168058
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices (EMBOLIZE)
Randomized Controlled, Single-Blinded, Parallel-Group Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices (EMBOLIZE) Trial
The purpose of this study is to see if a randomized controlled trial of ovarian vein and pelvic vein embolization versus venography alone could determine outcomes for women with chronic pelvic pain and pelvic varicose veins.
The data gathered will assist in addressing changes in quality of life in patients who have ovarian/pelvic vein embolization versus no embolization.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ronald S Winokur, MD
- Phone Number: 646-962-9179
- Email: rsw9004@med.cornell.edu
Study Contact Backup
- Name: Jincy Koshy, MHA
- Phone Number: 646-962-2964
- Email: jlk4004@med.cornell.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern Medicine
-
Principal Investigator:
- Ramona Gupta, MD
-
Sub-Investigator:
- Kush Desai, MD
-
-
New York
-
New York, New York, United States, 10024
- Weill Cornell Medicine
-
Principal Investigator:
- Ronald S Winokur, MD
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina (UNC)
-
Principal Investigator:
- Gloria Salazar, MD
-
-
Washington
-
Bellevue, Washington, United States, 98004
- Lake Washington Vascular
-
Principal Investigator:
- Kathleen Gibson, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Presence of venous origin chronic pelvic pain for greater than 6 months (VAS ≥7) as delineated by the following criteria:
- Pain exacerbated by walking, standing or lifting
- Symptoms are at least partially alleviated by lying down
- Prolonged post-coital ache
- Absence of non-venous origin CPP as determined by Gynecology examination
- Symptoms-Varices-Pathophysiology Classification: S2V2PBGV,R,NT, S2V2PRGV,R,NT, S2V2PLGV,R,NT
- Left or right ovarian vein diameter greater than or equal to 6 mm
- Presence of pelvic varices as documented by transabdominal ultrasound or CT (≥1 veins, >5 mm diameter)
Exclusion Criteria:
- Female <18 years of age
- Pregnancy (positive pregnancy test)
- Female subject who plans to become pregnant during study period
- Female subject who is actively breastfeeding
- Patient who is post-menopausal or anovulatory
- Prior ovarian vein embolization or ovarian vein ligation
- Inability to tolerate endovascular procedure due to acute illness or general health
- Planned simultaneous treatment with nerve blocks during the duration of the study
- Laparoscopy or planned surgical intervention during the duration of the study
- Known allergy to sclerosant, coil, stent or catheter components including nickel allergy
- Significant iliac vein stenosis defined as >61% area reduction as determined by the investigator at the time on pelvic DUS or CT venogram prior to study procedure
- Significant renal vein stenosis with resultant hilar varices and lumbar collaterals as determined by the investigator at the time of venography
- Serious medical condition that might preclude full participation in the study to the desired endpoint (e.g., uncontrolled diabetes, malignancy, COPD, MI, CHF, etc.)
- Severe allergy to iodinated or gadolinium-based contrast refractory to steroid premedication
- Severe renal impairment (on chronic dialysis or estimated GFR <30 mL/min)
- Hemoglobin <8.0 g/dL, uncorrectable INR >3.0 or platelet count <75,000/microliter
- Inability to provide informed consent or to comply with study assessments
- Post thrombotic IVC, iliac or ovarian vein changes
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Transcatheter Venography
|
Venographic assessment of ovarian veins and internal iliac veins
Other Names:
|
Experimental: Bilateral Ovarian Vein Embolization
Transcatheter Venography plus Bilateral Ovarian Vein Embolization.
|
Venographic assessment of ovarian veins and internal iliac veins
Other Names:
Intervention will include sclerosis of pelvic varices and coil embolization of the bilateral ovarian veins.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Visual Analog Scale (VAS) for pelvic pain
Time Frame: Weekly for 4 weeks prior to Day 1 and at 30, 90 and 180 day follow up
|
The VAS pain score is a standard scale from 0 to 10, defining 0 as ''no pain'' and 10 ''worst pain possible.''
|
Weekly for 4 weeks prior to Day 1 and at 30, 90 and 180 day follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) 3A Pain Intensity Scale
Time Frame: Weekly for 4 weeks prior to Day 1 and at 30, 90 and 180 day follow up
|
The Patient-Reported Outcomes Measurement Information System (PROMIS) 3A Pain Intensity Scale assess how much a person hurts.
The scale ranges from 1-5, defining 1 as ''no pain'' and 5 ''very severe pain.''
|
Weekly for 4 weeks prior to Day 1 and at 30, 90 and 180 day follow up
|
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) 10 Pain Intensity Scale
Time Frame: Weekly for 4 weeks prior to Day 1 and at 30, 90 and 180 day follow up
|
The Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health measures assess an individual's physical, mental, and social health.
The scale scores from from 5 to 1 with 5 = "Excellent" and 1= "Poor ".
|
Weekly for 4 weeks prior to Day 1 and at 30, 90 and 180 day follow up
|
Change in Patient Global Impression of Change (PGIC)
Time Frame: 30, 90 and 180 day follow up
|
The self-report measure Patient Global Impression of Change (PGIC) reflects a patient's belief about the efficacy of treatment.
PGIC is a 7 point scale with 1= "Very Much Improved" and 7= "Very Much Worse".
|
30, 90 and 180 day follow up
|
Change in EuroQol five-dimension (EQ-5D) scale
Time Frame: Weekly for 4 weeks prior to Day 1. Then at 30, 90 and 180 day follow up
|
The EuroQol five-dimension (EQ-5D) is a concise, generic measure of self-reported health at each visit.
Patients will tick the one box that best describes their health on that day.
This scale will measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.The scale is numbered from 0 to 100.
=100 means the best health the patient can imagine and 0 means the worst health the patient can imagine,.
|
Weekly for 4 weeks prior to Day 1. Then at 30, 90 and 180 day follow up
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ronald S Winokur, MD, Weill Medical College of Cornell University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-08026405
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Pain
-
University of California, San FranciscoStanford University; National Center for Complementary and Integrative Health...CompletedPelvic Pain | Chronic Pelvic Pain | Recurrent Pelvic PainUnited States
-
Foundation University IslamabadActive, not recruitingPregnancy Related Pelvic Girdle PainPakistan
-
Istanbul University - Cerrahpasa (IUC)CompletedPregnancy | Genito-Pelvic Pain | Pelvic Floor Muscle ExerciseTurkey
-
Aijun SunSecond Hospital of Jilin University; Guangzhou Women and Children's Medical... and other collaboratorsUnknownChronic Pelvic PainChina
-
Assiut UniversityCompletedIntractable Pelvic Cancer PainEgypt
-
Beijing Konruns Pharmaceutical Co., Ltd.CompletedChronic Pelvic PainChina
-
Weill Medical College of Cornell UniversitySociety of Interventional Radiology Foundation; EvideraEnrolling by invitationChronic Pelvic Pain Syndrome | Pelvic Congestive SyndromeUnited States
-
Helse Stavanger HFUniversity of StavangerCompletedPelvic Girdle Pain Post Partum | Low Back Pain Post PartumNorway
-
Oslo University HospitalStiftelsen Helse og RehabiliteringCompletedPelvic Pain | Pelvic Joint InstabilityNorway
-
Riphah International UniversityCompletedPelvic Girdle PainPakistan
Clinical Trials on Transcatheter Venography
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Multiple Sclerosis Society of...Completed
-
Xuanwu Hospital, BeijingThe People Hospital of Baoan ShenzhenActive, not recruitingArterial AneurysmChina
-
Sohag UniversityRecruitingAnatomical Variants of Dural Sinuses by Magnetic Resonance VenographyEgypt
-
Assistance Publique - Hôpitaux de ParisCompletedPulmonary ThromboembolismFrance
-
S. Anna HospitalRegione Emilia-RomagnaCompletedMultiple Sclerosis | Venous InsufficiencyItaly
-
Maastricht University Medical CenterUnknown
-
Assiut UniversityUnknownHemodialysis Access Failure
-
George Washington UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedLung Diseases | Pulmonary EmbolismUnited States, Canada
-
Assiut UniversityUnknown
-
Boston Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingEnd Stage Renal DiseaseUnited States